Click Here to return To Results

 

Rifaximin Treatment in Hepatic Encephalopathy NEJM 362:1071-1081, 1140, Bass,N.M.,et al, 2010 See this aricle in Pubmed Article Abstract Over a 6-month period, treatment with rifaximin maintained remission from hepatic encephalopathy more effectively than did placebo. Rifaximin treatment also significantly reduced the risk of hospitalization involving hepatic encephalopathy.

Related Tags

(click to filter results - removes previous filter) adverse drug reaction antibiotics cirrhosis complications encephalopathy hepatic encephalopathy hospital length of stay liver disease rifaximin safety treatment of neurologic disorder

Click Here to return To Results